A Core Outcome Set for Trials in CKD: Report of the Standardized Outcomes in Nephrology–Chronic Kidney Disease (SONG-CKD) Stakeholder Workshops

Omitting outcomes of importance to patients with chronic kidney disease (CKD) and their
caregivers from trials can impede decision-making based on patient-centered outcomes. As
part of the global Standardized Outcomes in Nephrology – Chronic Kidney Disease (SONG
CKD) initiative, we aimed to establish a consensus-based set of core outcomes for trials in
CKD (prior to the need for kidney replacement therapy). To finalize the proposed set of core
outcomes that were identified through focus groups and an international Delphi survey, we
convened two international stakeholder workshops in English and Spanish languages that
involved 61 patients/caregivers and 75 health professionals from 18 countries. Participants
were asked to discuss and endorse the potential core outcomes (mortality, kidney function,
life participation, and cardiovascular disease), and to provide suggestions for implementing
the core outcomes. The discussions were summarized into four themes: reflecting a
comprehensive approach to health, facilitating patient empowerment in their own care,
ensuring applicability to broad geographic areas and populations, and feasibility for
implementation. Patients, caregivers, and health professionals agreed that mortality, kidney
function, life participation and cardiovascular disease should be established as core outcomes
for trials in CKD.

Contributors

Andrea Matus Gonzalez, Rosanna Cazzolli, Nicole Evangelidis, Benedicte Sautenet, Yeoungjee Cho, Laura Cortes Sanabria, Jonathan C. Craig, Ian H. de Boer, Samuel Fung, Daniel Gallego, Chandana Guha, Jenny I. Shen, Andrew S. Levey, Adeera Levin, Eduardo Lorca, Sebastian Cabrera, Haydee Mellado, Soledad Molina, Ximena Atilano, Lorena Sandino, Macarena Arancibia, Alejandro Sepulveda, Marcelo Urra, Maria de los Angeles Bravo, Karine Manera, Javier Recabarren, Ikechi G. Okpechi, Patrick Rossignol, Nicole Scholes-Robertson, Laura Sola, Armando Teixeira-Pinto, Tim Usherwood, Andrea K. Viecelli, David C. Wheeler, Katherine Widders, Allison Jaure

Publication

Journal: American Journal of Kidney Diseases
Volume:
Issue:
Pages: -
Year: 2025
DOI: 10.1053/j.ajkd.2024.10.013

Further Study Information

Current Stage: Completed
Date:
Funding source(s): AMG is supported by Agencia Nacional de Investigación y Desarrollo (ANID) Becas Chile - Doctorado en el extranjero (72210455). A.J is supported by a NHMRC Fellowship (APP1106716). The other authors declare that they have no relevant financial interests.


Health Area

Disease Category: Kidney disease

Disease Name: Chronic kidney disease

Target Population

Age Range: 18 - 120

Sex: Either

Nature of Intervention: Any

Stakeholders Involved

Study Type

- Recommendations made

Method(s)

- Semi structured discussion